Momenta Pharmaceuticals, Inc. (MNTA)

[Mpower]

The story is phenomenal, the performance for shareholders has thus far been abysmal. I am not a trader and have been following MNTA since 2005, I just wonder if this stock will be in the unfortunate situation of having a great product, tons of revenue but will always be in purgatory for fear of one event or another. (e.g. today its a threat from TEVA, tomorrow it will be something else)

In short, I don't see a material event in the horizon that will make up for the lack of wall street charm. The only hope for shareholders is that a large company (like Novartis) will see value and acquire the company.

No attempt by Wheeler et. all to get the market excited about MNTA's technology. No CNBC interviews, no major news networks highlighted the technological differentiation, no attempt to exploit the interest of the public or congress on FoB. The only true advocate was the FDA, and they were attacked relentlessly. In fact, the FDA was a better advocate for MNTA, than MNTA is for itself. As for Wheeler -- being a good speaker is necessary but not sufficient to effective communication. MNTA needs some serious help with their PR.

I will make my displeasure about Wheelers inability to effectively manage the post approval environment known to MNTA management and the BoD. Sitting on our hands and demonizing a "short-term perspective" seems to be a cop-out to me.

Disclosure: I have reduced my holdings in the past few days (not significantly, but as a hedge) --- After reviewing this more closely over the weekend (after deep thought, meditation and contemplation), I don't expect this stock to go anywhere in the near future. Ultimately, I think the raising of $$$'s without any attempt to justify the raise heightens the risk of a TEVA generic Lovenox approval. (It doesn't makes sense to raise a measly 50 million bucks for FoB (at 14$ a share) when the company is generating that quarterly revenue from mL sales.